Sera PrognosticsSERA -0.82%70 Market Cap is $71.47 Mil as of Jun. 25, 2026. GuruFocus rates SERA with a GF Score™ of 70/100 and a GF Value™ of $1.86 (Fairly Valued). The stock has 5 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Sera Prognostics ranks worse than 56.12% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sera Prognostics's share price for the quarter that ended in Mar. 2026 was $2.03. Sera Prognostics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 39.14 Mil. Therefore, Sera Prognostics's market cap for the quarter that ended in Mar. 2026 was $79.46 Mil.
Sera Prognostics's quarterly market cap
declined
from Sep. 2025 ($118.02 Mil) to Dec. 2025 ($114.89 Mil) and
declined
from Dec. 2025 ($114.89 Mil) to Mar. 2026 ($79.46 Mil).
Sera Prognostics's annual market cap
increased
from Dec. 2023 ($189.59 Mil) to Dec. 2024 ($278.18 Mil) but then
declined
from Dec. 2024 ($278.18 Mil) to Dec. 2025 ($114.89 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sera Prognostics's Enterprise Value for Today is $26.57 Mil.
Sera Prognostics (NAS:SERA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sera Prognostics Market Cap Related Terms
Sera Prognostics Market Cap Historical Data
* Premium members only.
The historical data trend for Sera Prognostics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sera Prognostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sera Prognostics Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sera Prognostics's Market Cap distribution charts can be found below:
* The bar in red indicates where Sera Prognostics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sera Prognostics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sera Prognostics (SERA) has a Market Cap of $71.47 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sera Prognostics and its competitors. According to the industry distribution chart, Sera Prognostics ranks #486 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 56.1%.
Is Sera Prognostics' Market Cap too high?
Sera Prognostics' current Market Cap is $71.47 Mil. The Medical Devices & Instruments industry median Market Cap is 122.56. Sera Prognostics' value of $71.47 Mil is 41.7% below this industry median. Based on the distribution chart, Sera Prognostics ranks #486 out of 866 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sera Prognostics has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sera Prognostics' Market Cap compare to ECOR and OM?
According to the Medical Devices & Instruments industry distribution chart, Sera Prognostics ranks #486 out of 866 companies for Market Cap. This places Sera Prognostics in the lower half of its industry. The industry median Market Cap is 122.56. Sera Prognostics' value of $71.47 Mil is 41.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.56, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sera Prognostics's current Market Cap of $71.47 Mil is 41.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sera Prognostics and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sera Prognostics's current Market Cap is $71.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sera Prognostics stock overvalued right now?
Based on GuruFocus' analysis, Sera Prognostics (SERA) is currently considered Fairly Valued. The stock's GF Value™ is $1.86, compared to a current price of $1.83 — trading 1.9% below its estimated fair value. The current Market Cap is $71.47 Mil and 41.7% below the Medical Devices & Instruments industry median of 122.56. Sera Prognostics' overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sera Prognostics (SERA), the current Market Cap is $71.47 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sera Prognostics (SERA) Overvalued in 2026?
Based on GuruFocus' analysis, Sera Prognostics stock appears to be undervalued.
The current stock price of $1.83 is trading 1.9% below its estimated GF Value™ of $1.86.
GuruFocus considers Sera Prognostics to be Fairly Valued.
Key valuation signals for SERA:
Market Cap: $71.47 Mil
GF Value™: $1.86 vs. price of $1.83 (1.9% below fair value)
Industry Position: 41.7% below the Medical Devices & Instruments median (#486 of 866)
No single metric tells the full story. See the SERA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
70GF Score
Get the complete analysis for SERA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SERA has been successfully added to your 
